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5ABSTRACT
Dual chamber pacing can be employed to restore atrioventricular synchrony in 
patients with heart block; and chronotropic incompetence and sinus bradycardia in 
those with sinus node dysfunction (SND). The focus of this thesis is the feasibility and 
consequences of proper atrial sensing and pacing to atrioventricular (AV) synchrony 
in dual chamber pacing. All the studies were conducted with patients who had a 
clinical indication for dual chamber pacing.
The first study in patients with isolated AV block showed that single lead VDD 
pacing (single pass ventricular lead with a dual chamber electrode system) can be 
an alternative to standard dual chamber pacing systems. Adequate sinus-driven 
atrial rate and no history of paroxysmal atrial fibrillation or cardiac enlargement 
predict reasonably good long-term maintenance of the VDD pacing mode in elderly 
patients treated for heart block. 
The results of the second study showed that retrograde atrial waves can be 
discriminated from sinus waves in many patients by using a high sampling rate 
and algorithms for digital signal processing with data collected by a pacemaker 
(PM). This approach could enhance the capability of future devices to adapt their 
stimulation to the spontaneous heart rhythm and improve the collection of diagnostic 
information on arrhythmias.
The third study showed that the atrial tachyarrhythmia (AT) sensing algorithms 
incorporated in a state-of-the art DDDR (dual lead atrioventricular pacing) 
pacemaker can accurately identify patients who develop ATs. However transient 
undersensing of continuous atrial fibrillation (AF) and failure to detect very short 
episodes ATs can occur frequently, despite the use of refined detection algorithms. 
With a fixed long AV delay in DDDR pacing as in this study, temporal disruption of 
AV synchrony and inappropriate mode switch (MS) due to repetitive non-reentrant 
ventriculo-atrial synchronous rhythm (RNRVAS) is relatively common with SND 
patients (in 25%)  in the presence of  retrograde VA conduction.
In the fourth study an advanced atrio ventricular search hysteresis (AVSH) 
algorithm reduced incidence of unnecessary ventricular pacing in the majority of 
SND patients with both intact and impaired AV conduction and in patients with 
intermittent AV block, regardless of the lead positions in the right atrium and the 
ventricle. The avoidance of possible harmful right ventricular (RV) pacing with 
used state of art AVSH algorithm was not associated with unphysiological over-
long AV delays.
In conclusion, proper atrial detection and timing for atrioventricular pacing is 
also feasible in the long-term with contemporary clinical pacing. With appropriate 
6programming, these devices may contribute to the avoidance of possible adverse 
consequences like congestive heart failure, atrial fibrillation and unwanted harmful 
symptoms. In future devices with digital signal processing the detection of atrial 
signals can be further improved.
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8ABBREVIATIONS
AF atrial fibrillation
AT atrial tachyarrhythmia
ATDR  atrial tachycardia detection rate
AV atrioventricular
AVI atrioventricular intervals
AVSH atrioventricular search hysteresis
CRT cardiac resynchronization therapy
DSP digital signal processing
FF far field
FP form parameter
ICD implantable cardioverter defibrillator
MS mode switching
PM pacemaker
PMT  pacemaker tachycardia
PVAB post ventricular atrial blanking
PVARP  post ventricular atrial refractory period
RA right atrial
RNRVAS repetitive non-reentrant ventriculo-atrial synchronous rhythm
RV right ventricular
SND sinus node dysfunction
VP ventricular pacing
VIP™ Ventricular Intrinsic Preference
91 INTRODUCTION
The number of  implanted cardiac pacemakers (PM) continues to grow in the western 
world as pacing indications broaden and life expectancy becomes longer. Enormous 
progression in new technologies and comprehensive research ensure improved and 
more versatile device-based therapies to expanding patient populations. Currently 
there are more than two million patients worldwide with implanted PM devices 
(Ellenbogen et al. 2011). The most commonly implanted PM devices are designed 
to manage patients’ bradycardia, but there has been a major increase in the use 
of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization 
therapy (CRT).  All of them basically adhere to the same basic principles of cardiac 
pacing in attempting to restore normal electrical activation of the heart (Epstein et 
al. 2008, Vardas et al. 2007, Ellenbogen et al. 2011).
The original indication for permanent pacing in the late 1950`s was complete 
heart block. The first mode of pacing was asynchronous ventricular pacing. Although 
the results from this therapy were remarkable the number of patients who benefited 
from these early pacemakers was very limited. Since this early experience, the 
indications have widened as have the available pacing modes. The complexity and 
diversity of pacing devices has allowed significant improvement to a patient’s quality 
of life and also survival. At the same time, there has been a growing recognition 
that when programmed inappropriately, these devices may contribute to adverse 
consequences like congestive heart failure, atrial fibrillation (Sweeney et al. 2003, 
Sweeney et al. 2006) and unwanted harmful symptoms like palpitations, dizziness 
and exercise intolerance.
The goal of permanent bradycardia pacing is to correct the slow heart rhythm 
caused by diseased tissues comprising the conduction system of the heart. In heart 
block, atrioventricular synchrony; and in sinus node dysfunction sinus bradycardia 
and poor increase of heart rate during exercise are restored by pacing the heart. 
Both therapies are best accomplished with a dual chamber PM (Gillis et al. 2012). 
However, the basic principle of pacing is to fix only what is broken, because 
normal electrical activation of the heart is always more physiological than the 
rhythm generated by electrical stimulation of the heart. Pacing induces electrical 
desynchronization of the paced chamber and thus unnecessary pacing of both 
the atria and the ventricles should be avoided. Prerequisites of dual chamber 
pacing are: adequate sensing of the normal sinus activation and possible atrial 
arrhythmias, successfully and appropriately implanted transvenous endocardial 
pacing leads and finally patient tailored programming of sensing and pacing of 
the PM device.
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Proper sensing of sinus beats is a key function to atrial driven ventricular or 
non-triggered dual chamber pacing. With current analogue PM technology, cardiac 
events are classified on the basis of the time-lag between consecutive sensed events. 
With digital technology devices can continuously monitor and classify every sensed 
event, thereby dramatically increasing the amount of information that can be 
processed and stored. PM algorithms using both morphology and timing criteria 
might significantly improve atrial signal sensing and classification.
Atrial tachyarrhythmias (ATs) especially atrial fibrillation are common among 
PM patients. Mode switching (MS) from atrial driven ventricular pacing to non-
triggered pacing during episodes of ATs is also a key function in dual chamber 
pacing. Modern pacemakers provide detailed information of the MS and AT 
episodes, but these functions unfortunately can also fail in the recognition of ATs 
due to interrupted sensing of atrial fibrillation, persistent oversensing of far field 
(FF) ventricular signals or sensing of retrograde atrial depolarizations. 
Atrial pacing, like ventricular pacing in the ventricles, changes the electrical 
activation order of the atria and is influenced by the atrial pacing site (Roithinger 
et al. 2001, Strohmer et al. 2004). Consequently induced intra and inter atrial 
desynchronization with prolonged AV conduction time can be disadvantageous. 
Different atrial and ventricular lead locations also influence the device 
programmed atrioventricular timings, attaining adequate AV synchrony and 
on the amount of unnecessary and potentially harmful ventricular pacing (VP).
In modern dual chamber pacing a fundamental PM requirement is to avoid 
unnecessary ventricular pacing but always pace the ventricles when it is considered 
inevitable and deliver that stimulation appropriately timed to ensure physiological 
AV synchrony (Ellenbogen et al. 2011). The development of pacing algorithms to 
reliably avoid the former and deliver the latter, timely and safely, has been a focus 
of current clinical research in the field of cardiac pacing.
The acceptance that the loss of AV synchrony with only ventricular pacing could 
cause symptoms began in the late 1970’s, with the introduction of dual chamber 
pacing and the increase in the use of single chamber atrial pacemakers (Ellenbogen 
et al. 2011). In the early 1990’s the pacing community started to appreciate that 
patients with SND, intact AV nodal conduction and a normal ventricular activation 
pattern might do better with atrial only pacing rather than atrioventricular pacing. 
This was due to the fact that right ventricular pacing modifies the electrical activation 
and the contraction pattern of the ventricles and this has been linked to an increased 
risk of AF and heart failure (Sweeney et al. 2003). Thus in patients with SND, 
bradycardia should be treated by pacing the atria and allowing the ventricles to 
be activated subsequently by intrinsic atrioventricular (AV) conduction. If the AV 
conduction is impaired, prolonged and unphysiologically long AV intervals (AVIs) 
may occur and should be avoided by dual chamber pacing using shorter, paced 
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AVIs. Also in patients with only intermittent AV block the ventricles should be 
allowed to activate by intrinsic AV conduction when possible. On the other hand, 
substantially prolonged AV conduction reduces ventricular preload and causes 
mitral regurgitation. It is also associated with development of AF (Cheng et al. 2009). 
Ideally, an algorithm in the PM should allow spontaneous ventricular activation 
when AV conduction is intact or slightly compromised to avoid pacing induced 
ventricular desynchronization. Alternatively, if the AV conduction occasionally or 
permanently is unfavourably disrupted, this algorithm should automatically switch 
the PM to use more physiological AV delays to avoid AV desynchronization. Then 
in the presence of persistent AV block, even first-degree AV block with a very long 
AVI, there is nothing to be gained by programming a fixed very long AV delay or 
enabling an algorithm aiming to avoid ventricular pacing (Ellenbogen et al. 2011).
The present series of studies was undertaken in the period 2002 to 2012 
in Helsinki University Hospital. The focus in these was on the feasibility and 
consequences of proper atrial sensing and pacing to atrioventricular synchrony in 
dual chamber pacing. All studies were conducted with patients that had a clinical 
indication for dual chamber pacing.
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2 REVIEW OF THE LITERATURE 
2.1 INDICATIONS OF DUAL CHAMBER PACING
The goal of atrioventricular synchrony is best accomplished with dual chamber 
pacing both in heart block and sinus node dysfunction (Gillis et al. 2012). When 
only ventricular pacing is used in patients with SND consequential loss of AV 
synchrony will cause symptoms like fatique and dizziness in 20-50% of these patients 
(Ellenbogen et al. 2011, Gillis et al. 2012). With heart block the restoration of AV 
synchrony with dual chamber pacing leads to better physical performance and less 
atrial fibrillation compared to single chamber ventricular pacing. This can also be 
achieved with single lead VDD pacing when the sinus node function is normal and 
thus there is no need for atrial pacing. In a substantial number of SND patients 
(9.3%) initially preserved AV conduction will deteriorate and thus a dual chamber 
PM should be implanted primarily (Nielsen et al. 2011). In patients with a poor 
and asynchronously contracting left ventricle, biventricular dual chamber pacing 
(CRT=cardiac resynchronization therapy) should be considered (Gillis et al. 2012). 
With an ICD indication the same principles of bradycardia pacing are applied when 
SND or disturbances of AV conduction are observed (Epstein et al. 2008).  
2.2 MAINTAINING AV SYNCHRONY IN DUAL CHAMBER  
 PACING
In the cardiac cycle atrial systole completes ventricular diastolic filling and, in 
normal hearts, can account for 40-50% of  the left ventricular filling (Sagie et 
al.1993, Kuo et al.1987). Hemodynamic advantages, reduction in the development 
of atrial fibrillation and better quality of life are gained by using a pacing mode 
which preserves normal atrioventricular synchrony in the cardiac cycle in preference 
to ventricular pacing on demand (Rediker et al.1988, Menozzi et al.1990, Nowak 
et al.1995, Conolly et al. 2000). In both patients with SND and with isolated AV 
block preserved AV synchrony can be achieved with DDDR pacing. In patients with 
isolated AV block single lead VDD pacing can be an alternative to standard dual 
chamber systems. Advantages of single lead VDD over regular DDD pacing are: less 
complex implant procedure, lower implantation and follow-up costs (Wiegand et 
al.1999, Wiegand et al. 2001). However, handicap for current VDD pacing is that 
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with a passive fixation VDD- lead only right ventricular apical pacing is feasible. 
Furthermore, new onset of sinus nodal dysfunction can be also a reason for losing 
AV synchrony in patients paced in VDD mode (Wiegand et al.1999). Both DDDR 
and VDD modes are currently recommended to be used in patients with isolated 
AV block (Gillis et al. 2012).
In dual chamber pacing loss of AV synchrony can be caused by various reasons, 
for example: improper atrial sinus beat sensing, atrial tachyarrhythmias and 
continued oversensing of far field (FF) ventricular signals or sensed retrograde 
atrial depolarizations from the ventricle. 
Atrial tachyarrhythmias especially atrial fibrillation are common reasons for PM 
patients to lose AV synchrony. Atrial tachyarrhythmias were observed in 89% and 
46% of patients with and without previously documented atrial tachyarrhythmias, 
respectively (Orlov et al. 2007). Mode switching (MS) from atrial driven ventricular 
pacing (DDD/DDDR/VDD) to ventricular based pacing (DDI/DDIR/VVIR) during 
episodes of ATs is a fundamental and established feature in dual chamber pacing 
(Vardas et al. 2007). 
Continued oversensing of far field (FF) ventricular signals (Kolb et al. 2006) or 
sensed retrograde atrial depolarizations from the ventricle (Barold et al. 2001) can 
cause inappropriate MS and loss of AV synchrony.  First of all, retrograde conduction 
is responsible for symptomatic conditions such as pacemaker-mediated tachycardia 
(PMT) which can occur when ventricular events are conducted retrogradely to the 
atria and the PM senses these atrial depolarizations and then deliver a stimulus to 
the ventricle, causing depolarization, that again is conducted retrogradely to the atria 
which, if repeated, causes PMT (Barold et al. 2007). For the DDD(R) pacing mode 
with retrograde conduction, a long post-ventricular atrial refractory period (PVARP) 
is programmed to prevent PMT. However, programming a long PVARP does not 
prevent the patient from experiencing repetitive, non-reentrant, ventriculo-atrial, 
synchronous rhythm (RNRVAS) (Figure1), which leads to loss of AV synchrony 
like PMT (Barold et al. 2001). With DDDR pacing individual adjustment of the 
post-ventricular atrial blanking period (PVAB) significantly reduces inappropriate 
sensing due to FFs. If atrial sensitivity value is set to 0.3 mV inappropriate FF sensing 
can be seen in 10% of the patients (Kolb et al. 2006). To prevent FF oversensing 
it is necessary to program a sufficiently long PVAB and decreased atrial sensitivity 
value. It is also of note that FF signals are dependent on the lead location in the 
right atrium (Ellenbogen et al. 2011). 
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Figure 1. In RNRVAS, the retrograde atrial depolarization falls inside the programmed PVARP and, therefore 
does not trigger ventricular pacing. The atrial pacing stimulus (A) does not capture the atrium, which is 
refractory. The next ventricular paced event (V) again retrogradely activates the atrium (P in a box) and 
RNRVAS is initiated. Marker channel (top) and atrial EGM (bottom). 
2.3 THE REqUIREMENT OF ATRIAL BEAT SENSING FOR AV  
 SYNCHRONY
The role of proper sensing of atrial beats is important because poor and erroneous 
sensing can cause loss of AV synchrony, inappropriate pacing and arrhythmias. 
Commonly atrial sensitivity is programmed to a value of one third of the measured 
atrial signal amplitude to achieve proper sensing of the spontaneous sinus rhythm 
(Ellenbogen et al. 2011). In the case of atrial oversensing, atrial sensitivity can be 
decreased to a value where undersensing of  atrial wave is not observed. With a 
permanent active or passive fixation atrial lead in DDDR pacing the proper function 
of atrial sensing is relatively easy to achieve at implantation and it also remains stable 
in the long term (Wiegand et al.1999). With single lead VDD pacing where the atrial 
sensing dipole is floating in the right atria sufficient atrial sensing is more difficult to 
achieve. However, adequate atrial sensing can be obtained utilising a wide range of 
the atrial sensing dipole positions from top to the lateral bottom region of the right 
atrium with no signal impairment in long-term (Sun et al.1998). Although atrial 
sensing varies considerably according to the body postures (Toivonen et al.1996, 
Sun et al.1998) and intermittent atrial undersensing is not unusual, prolonged 
and symptomatic atrial undersensing needing VDD pacemaker upgrading is rare 
(Chamberlain-Webber et al.1998, Wiegand et al.1999).
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Ideally, an implanted cardiac pacemaker should be able to detect and interpret 
the cardiac rhythm continuously in real time. The difficulty of classifying signals 
correctly remains a weakness of current analogue technology, despite the use of 
appropriate filters and careful programming (Padeletti et al. 2005). The signal passes 
through an analogue amplifier, where it is magnified, and a filter attempts to screen 
out undesired components while allowing the passage of useful ones. The sensing 
circuit compares the amplitude of the signal with a threshold value determined by 
the programmed sensitivity. An analogue pacemaker cannot “classify” the shape 
of the signal, discriminate between sinus and retrograde atrial waves or identify 
ventricular FF deflection in the atrial channel. With analogue technology, cardiac 
events are classified merely on the basis of the time-lag between consecutive sensed 
events. Consequently, all decisions regarding data collection and stimulation therapy 
are based on the timing of the sensed signal.
Digital signal processing (DSP) of intracardiac signals (Chiang et al.1994) is 
available in pacemaker technology (Throne et al.1989, Strooband et al. 2002, 
van Hemel et al. 2004, Padeletti et al. 2005, Lewalter et al. 2007). In DSP, the 
input signals entering the pacemaker are converted into a quantifiable number of 
values within a certain time-window and are utilized for device decisions regarding 
stimulation therapy and data collection. Digital devices can continuously monitor 
and classify every sensed event by using specific form parameters (FPs), thereby 
dramatically increasing the amount of information that can be processed and stored. 
Algorithms using morphology and timing criteria can significantly improve atrial 
signal sensing and classification, since they allow for high atrial sensitivity and 
short blanking periods. Unfortunately this technology is not currently available in 
clinical pacing.
2.4 DETECTION OF ATRIAL TACHYARRHYTHMIAS
Atrial tachyarrhythmias (ATs) especially atrial fibrillation are common among 
pacing device  patients. Modern pacemakers provide detailed information of AT 
episodes that help therapeutic decision making such as the need for changes in 
pacemaker programming, anticoagulation or anti-arrhythmic medication.  A reliable 
AT detection is thus critical for proper pacemaker patient care (Glotzer et al. 2003, 
Nowak et al. 2005, Tse et al. 2005). 
Unfortunately PMs can also fail in the recognition of ATs. Undersensing of 
continuous atrial fibrillation and very short ATs are not uncommon and can cause 
inadequate AT detection (De Voogt et al. 2006). Also continued oversensing of 
FF ventricular signals (Kolb et al. 2006) or sensed repetitive retrograde atrial 
depolarizations from the ventricle (Barold et al. 2001) can cause false AT detection. 
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With SND patients long atrioventricular delays are usually programmed to 
prevent possibly harmful right ventricular pacing (Nielsen et al. 2003, Sweeney 
et al. 2003, Olshansky et al. 2007, Nitardy et al. 2009). Long PVARPs are usually 
needed to hinder pacemaker tachycardias in DDDR mode. Programming a long AV 
delay and a long PVARP will on the other hand predispose to RNRVAS leading to 
inappropriate atrial arrhythmia detection in both DDDR and DDIR modes (Barold 
et al. 2001). 
To prevent FF oversensing a sufficiently long PVAB programming is needed 
but a long PVAB unfortunately contributes to undersensing of atrial arrhythmias 
(De Voogt et al. 2006). Thus with all these programmable parameters there are 
trade-offs affecting the desired functioning of the PM and to the recognition of atrial 
arrhythmias. Recent studies have fortunately demonstrated that with a novel atrial 
lead designed with a short tip-ring distance of 1.1 mm a more sensitive setting than 
0.5 mV can be used without inappropriate FF oversensing and lead to potential 
improvements in recognition of atrial arrhythmias (De Voogt et al. 2005, De Groot 
et al. 2008).
2.5 CONSEqUENCES OF ATRIAL PACING TO INTRA-AND  
 INTERATRIAL CONDUCTION TIMES
Atrial systole has a major contribution to ventricular filling, thus its timing with 
respect to AV synchrony is important. Atrial pacing changes the electrical activation 
of the atrias (Belham et al. 2002, Roithinger et al. 2001, Strohmer et al. 2004). 
During atrial pacing the atrial depolarization has a non-physiological propagation 
and conduction time. Compared with sinus rhythm, atrial pacing prolongs the 
duration of atrial activation and delays the onset of atrial systolic contraction 
(Belham et al. 2002). Consequently induced AV desynchronization with prolonged 
AV conduction time can be disadvantageous especially when the AV conduction 
is initially compromised. Prolonged intra-atrial, inter-atrial and AV conduction is 
not uncommon in patients with SND and a history of atrial tachyarrhythmias. The 
prolonged PQ interval probably reflects a prolonged atrial conduction time likely to 
be caused by atrial fibrosis and atrial dilatation, that may be involved in the substrate 
for atrial fibrillation. Atrial pacing can cause undesirable atrial desynchronization 
and further prolong conduction times and thus exert a detrimental effect on atrial 
electromechanical function. Subsequent delay in left atrial contraction can diminish 
left ventricular filling, leading to higher atrial pressure and thus an increased risk of 
atrial fibrillation. Right atrial septal pacing is associated with significantly shorter 
atrial conduction time and P wave duration, compared to common right atrial pacing 
sites at the right atrial appendage or at the right free wall (Strohmer et al. 2004). 
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Different atrial and also ventricular lead locations may have an influence on PMs 
AV timing, AV synchrony and on the amount of possibly unnecessary and harmful 
VP. While atrial pacing can further prolong intra- and inter-atrial conduction times, 
there can be an additional delay between the atrial pacing stimulus and the onset of 
the atrial depolarization. Thus, the time from atrial pacing stimulus to spontaneous 
ventricular activation is likely to be significantly longer than the actual PR interval 
on the ECG. These differences must be noted when programming the PMs AVIs 
to achieve optimal physiological AV synchrony (Ellenbogen et al. 2011). Also when 
programming atrial paced AVIs with heart block, the fact that atrial pacing prolongs 
intra- and interatrial conduction times should be taken in to account. Thus it 
is recommended to use longer atrial paced than sensed AVIs also when pacing 
heart block. And if the spontaneous PQ interval does not shorten during exercise, 
shortening of AVIs in DDDR pacing is recommended to be programmed in order 
to achieve physiologic AV synchrony also during exercise (Ellenbogen et al. 2011).
2.6 RELATIONSHIP BETWEEN MAINTAINING PROPER AV  
 SYNCHRONY AND AVOIDING UNNECESSARY  
 VENTRICULAR PACING
2.6.1 AVOIDING UNNECESSARY VENTRICULAR PACING
In patients with SND, bradycardia should be treated by pacing the atria and allowing 
the ventricles to be activated subsequently by normal intrinsic AV conduction. If 
the AV conduction is impaired, prolonged and unphysiologically long AVIs may 
occur and can be avoided by dual chamber pacing using shorter, paced AVIs. Also 
in patients with only intermittent AV block the ventricles can be allowed to activate 
by intrinsic AV conduction when possible (Vardas et al. 2007, Epstein et al. 2008, 
Ellenbogen et al. 2011). Also notable is that the AVIs with PM patients as perceived 
by the PM depends not only on the intrinsic AV conduction, but also on the positions 
of the atrial and the ventricular leads (Roithinger et al. 2001, Strohmer et al. 2004, 
Belham et al. 2002). With almost a tenth of SND patients initially preserved AV 
conduction will deteriorate in coming years and thus a dual chamber PM, instead 
of only atrial pacing, is preferable for most of these patients (Nielsen et al. 2011, 
Gillis et al. 2012). However, in both SND patients and patients with intermittent 
AV block the use of dual chamber PM, programmed with physiological AVIs usually 
cause unnecessary VP (Gillis et al. 2006, Milasinovis et al. 2006, Sweeney et al. 
2007, Murakami et al. 2010, Kolb et al. 2011). Right ventricular, especially apical, 
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VP modifies the electrical activation and the contraction pattern of the ventricles 
and results in higher atrial pressures (Van Oosterhout et al. 1998 ). This has been 
linked to an increased risk of AF and heart failure (Karpawich et al.1999, Thambo 
et al. 2004,  Andersen et al.1997, Lamas et al. 2002, Connolly et al. 2000, Skanes et 
al. 2001, Sweeney et al. 2003). A common perception is that AF, HF hospitalizations 
and death show a long term reduction if %VP is kept below 40% and minimized 
when %VP falls close to 10% (Sweeney et al. 2003, Wilkoff et al. 2002, Olhansky et 
al. 2007). Pacing induced ventricular desynchronization seems to be most harmful 
in the failing heart (Sweeney et al. 2003, Steinberg et al. 2005). 
2.6.2 MAINTAINING PHYSIOLOGICAL AV SYNCHRONY
Substantially prolonged AV conduction reduces ventricular preload and causes 
mitral regurgitation (Ishikawa et al.1992) and is also associated with development 
of AF. A longer PQ-interval (>200ms) has been found to double the risk of AF 
in population studies (Cheng et al. 2009). The same association has also been 
found in SND patients (Nielsen et al. 2012). Furthermore, atrial pacing induced AV 
desynchronization with a prolonged AV conduction time seems to be disadvantageous 
when the AV conduction is initially compromised and especially in the presence of 
heart failure (Sweeney et al. 2010). With heart failure patients the use of commonly 
programmed or default AVIs with too early ventricular capture can diminish left 
ventricular filling leading to higher atrial pressures and thus increasing the risk of 
AF (Sanagala et al. 2011). On the contrary, in patients with preserved left ventricular 
function, DDDR pacing with full ventricular capture, delivered after an AVI that 
allows completion of atrial contraction, seems to have no detrimental effects on the 
left atrial function and enlargement (Ellenbogen et al. 2011). 
2.6.3 PACEMAKER ALGORITHMS TO ENSURE PHYSIOLOGICAL AV INTERVALS  
 WHILE REDUCING UNNECESSARY VENTRICULAR PACING
Different atrioventricular search hysteresis (AVSH) algorithms in PMs basically 
allow spontaneous ventricular activation when AV conduction is intact or slightly 
compromised avoiding pacing induced ventricular desynchronization. And 
alternatively, if the AV conduction occasionally or permanently is prolonged 
unfavourably, these algorithms should automatically switch the PM to use more 
physiological AV delays to avoid AV desynchronization (Ellenbogen et al. 2011).
An alternative strategy for the reduction of unnecessary VP instead of ASVH 
algorithms is the use of those PM algorithms which basically employ automatic 
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switching between AAIR and DDDR modes. Effected by a continuous search for 
spontaneous ventricular activation after a paced or sensed atrial event. These 
algorithms have shown to be more effective in reducing VP than AVSH algorithms 
in patients with intact, compromised AV conduction and with intermittent AV block 
(Murakami et al. 2010, Purerefellner et al. 2008, Stockburger et al. 2009). However, 
there are concerns related to these algorithms that allow relative bradycardia or 
an occurrence of short–long–short ventricular sequences and are linked with 
pause-mediated polymorphic ventricular tachycardia or ventricular fibrillation in 
patients with intermittent high grade AV block (van Mechelen et al. 2007). Also, 
these algorithms allow excessive (>350ms) atrial paced or sensed AVIs which can 
be hemodynamically detrimental and are linked to symptomatic episodes especially 
during exercise and increase risk of AF and mortality (Sweeney M et al. 2010, 
Stockburger et al. 2009). Although hemodynamics during normal ventricular 
activation are generally acknowledged to be superior to right ventricular apical 
pacing, hemodynamics during DDDR mode pacing with physiological AVIs seem 
to be superior to normal ventricular activation when the atrial paced AVI exceeds 
over 270 ms (Iliev et al. 2000). Thus the promotion of more physiological AVIs may 
outweigh the slight increment of VP with the use of AVSH algorithms compared to 
the frailties of these alternative (AAIR-DDDR) algorithms to minimize VP. 
An additional strategy to avoid unnecessary VP in SND patients with dual 
chamber pacing is the use of PMs long  fixed AV delays. However, when a long AV 
delay is programmed, RNRVAS is relatively common with patients in the presence of 
VA conduction (Barold et al. 2001). Interestingly while automatic AVSH algorithms, 
with prolonged AVIs, can also predispose to RNRVAS, they can also terminate it by 
shortening of the AVIs during VP. With a short AVI the atrial pacing stimulus can 
capture the atrium, which is not any longer refractory and RNRVAS is terminated.
In the presence of high grade AV block, even in symptomatic first degree AV 
block with unphysiological long PQ interval, VP can not be avoided and there is 
nothing to be gained by programming a very long AV delay or by using ASVH or 
AAIR-DDDR algorithms (Ellenbogen et al. 2011). 
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3 PURPOSE OF THE STUDY
The series of studies reported were undertaken to investigate the feasibility and 
consequences of proper atrial sensing and pacing to atrioventricular synchrony on 
patients with a implanted dual chamber pacing device, and to assess the use of this 
information on clinical pacing.
Specific aims were:
1. To evaluate the maintenance of AV synchrony on long-term pacing in 
different patient groups
2. To establish the sensing of sinus and retrograde atrial beats
3. To assess how PM algorithms detect atrial tachyarrhythmias
4. To study the maintenance of AV synchrony with simultaneous avoidance 
of unnecessary ventricular pacing with DDDR pacing in patients with sinus 
node disease and a low grade AV block
5. To investigate the performance of an advanced AV delay hysteresis algorithm 
to ensure proper AV synchrony and the avoidance of unnecessary ventricular 
pacing in patients with intact or impaired intrinsic AV conduction regarding 
to different atrial and ventricular pacing lead locations 
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4 MATERIAL AND METHODS
4.1 STUDY I
Three hundred sixty-five patients having isolated high degree AV conduction 
received single lead VDD pacemaker at Meilahti hospital between October 1992 
and March 1999. With this pacing mode a non fixed floating atrial sensing dipole 
is used. The patients mean age was 74.5 ± 8.0 years. We evaluated whether routine 
clinical information of atrial arrhythmias, sinus node function and heart failure is 
sufficient to select patients to benefit in long-term from VDD pacing. Data on 12-lead 
and monitored electrocardiograms and routine clinical information at implantation 
of a VDD pacing system was collected retrospectively.  The cumulative maintenance 
of VDD pacing mode and the causes and their determinants of loss of the AV 
synchrony were assessed. 
4.2 STUDY II
The main objective of this study was to characterize morphological differences 
between sinus and retrograde atrial waves. With 14 patients intracardiac atrial signals 
were collected and analyzed through a dual chamber pacemaker to characterize their 
morphologies and discriminate retrograde from sinus atrial waves off-line. Patients 
had a PM capable of digital signal processing of intracardiac signals. Intracardiac 
unipolar and bipolar signals were collected at an 800 Hz sampling rate through a 
0.4 Hz high-pass filter. Sinus and retrograde atrial waves during ventricular pacing 
were recorded in the supine and upright positions. Eleven different form parameters 
were applied to describe atrial wave morphology (Figure 2).
4.3 STUDY III
In a prospective, single-center study a total of 60 patients with sinus node dysfunction 
were implanted a dual-chamber PM with algorithms for detection of ATs. The aim 
was evaluate the performance of PMs atrial tachyarrhythmia sensing algorithms in 
SND with DDDR pacing programmed with a fixed long atrioventricular delay. The 
study was done with a 3 months data collection period retrieved from the memory 
of PM and with a 7 day external Holter recording period. The right atrial lead was 
implanted in the low septum, the appendage or the lateral or anterior free wall, and 
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the right ventricular was implanted at the apex. The AVIs were programmed long 
enough to ensure spontaneous ventricular activation. FF sensing provocative test 
was made after 1-2 months from implantation. The presence of FFs acknowledged 
by the PM was specifically sought. To achieve sensed intrinsic atrial rhythm the 
atrial rate was programmed to its lowest value. The PVAB was programmed to its 
shortest value of 60 ms. FF sensing was measured at different AV delays (50, 150 
and 300 ms) and at different sensitivities (0.1, 0.3, 0.5 and 1.0 mV). Atrial bipolar 
sensing was used. The test was done also during atrial pacing as above but with 
the atrial rate programmed to 10 bpm above the intrinsic rate. 
Figure 2. Eleven different FP values were calculated to describe the atrial wave morphology: 1) the minimum 
amplitude, 2) the maximum amplitude occurring before the minimum, 3) the maximum amplitude occurring 
after the minimum, 4) the minimum value of the slew rate signal occurring between 2) and 1), 5) the 
maximum value of the slew rate signal occurring between 1) and 3), 6) the area between the times at 
which the atrial wave is negative, 7) the positive area preceding the negative area during a 30 ms window, 
and 8) the positive area in the 30 ms window after the negative area. In addition, the following ratios: 
2)/1), 3)/1) and 2)/3) were calculated. 
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4.4 STUDY IV
This clinical investigation was an international, multicenter, prospective, randomized, 
parallel, single-blind study. A total of 415 patients were recruited between August 
2006 and May 2008 in a total of 42 centers in 9 different countries. There were 40 
patients from Meilahti Hospital in the study. The last follow up visit was conducted 
on June 2009. The purpose of the study was to evaluate whether an advanced AV 
search hysteresis algorithm, Ventricular Intrinsic Preference (VIP™), reduces the 
incidence of unnecessary ventricular pacing in sinus node dysfunction patients 
with both intact (AVi) or compromised (AVc) AV conduction and in patients with 
intermittent AV block (AVc) regardless of the lead positions in the right atria and 
the ventricle. Patients were classified as having AVi conduction if the PQ interval 
was < 210ms in ECG and 1:1 AV conduction during atrial pacing up to 120 bpm 
with PQ interval < 350ms. Both AVi and AVc patients were randomized equally to 
VIP™ on or off. In the study VIP™ performed an intrinsic AV conduction search 
every 30 s for 3 consecutive atrial cycles with the extension of the PAV/SAV delays 
from basic values of 150/200ms to 300/350ms. Extended AV intervals were allowed 
for 3 cycles when VP occurred before returning to basic AV delays. The implanted 
lead locations in the atria (appendage, lateral, septal, anterior wall) and ventricle 
(apex, septal wall) were chosen by clinicians’ preference. The patients were classified 
into eight different atrioventricular pacing configurations by their ventricular and 
atrial lead positions. 
The primary endpoint of this study was the %VP at 12 months both in patients 
with intact or compromised AV conduction. Our special scope was the secondary 
endpoint: the change of AV conduction and its effect on %VP during the study. In 
addition, subanalysis of the secondary endpoint results describing the relationship 
between %VP and different atrial and ventricular lead locations were assessed.
4.5 STATISTICAL METHODS
Continuous variables were expressed as the mean ± SD and range, and the categorical 
variables were expressed as frequency and percentage in all the substudies. The 
primary analysis in the Study IV of %VP between VIP ON and OFF within both intact 
(AVi group) and compromised AV (AVc group) was analysed on intention-to-treat 
(ITT) basis and conducted using a non-parametric unpaired t test and Wilcoxon rank 
sum test, since the assumption for the unpaired t-test was violated. Kruskal-Wallis 
test, with a Monte Carlo estimates on Wilcoxon score, was used for the comparisons 
between the pacing configuration bearing lowest %VP and the other remaining 
pacing configurations, within VIP ON/OFF groups. Bonferroni adjustment on the 
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type I error was applied due to the multiple comparisons. Comparisons for other 
continuous data were implemented by unpaired t-test, or equivalent non-parametric 
test, if the normality assumption was violated. The normality was checked with the 
aid of normality test, QQ-plot and the box plot. All categorical characteristics data 
were compared using a chi-square test, or Fishers exact test, when more than 1 
cell had an expected frequency less than five. For the relationship between pacing 
configuration and Study IV group assignation, Cochran-Mantel-Haenszel test was 
implemented for the overall assessment. Chi square test was further used to perform 
the pairwise comparison, and the Bonferroni correction was applied on the Type I 
error due to the multiple comparison.
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5 RESULTS
5.1 MAINTAINING AV SYNCHRONY IN LONG-TERM PACING
In Study I the cumulative maintenance of VDD pacing mode in high grade AV block 
patients was 91.4% in a long-term follow up of 1.5+1.5 years. Loss of VDD mode 
was due to permanent atrial fibrillation in 16 (4.6%), sinus node dysfunction in 6 
(1.7%) and atrial undersensing in 11 (3.1%) of the patients.  Chronic AF developed 
in 23% of patients who had heart enlargement in chest roentgenogram and a 
history of paroxysmal atrial fibrillation or flutter. A criterion of normal sinus rate 
at implantation sufficiently predicted adequate sinus node function. Poor atrial 
sensing was not predicted by pre-implant characteristics. 
In study IV with an 11 month long term follow-up the maintenance of AV 
synchrony with DDD mode pacing in SND and low grade AV block patients was 
99.1%. DDDR pacing mode was permanently lost in only three patients (0.9%) 
who developed chronic AF.  
In Study III during the follow up period of 3 months RNRVAS caused temporary 
loss of DDDR mode and AV synchrony in 6 (11%) out of 54 SND patients seen on 
PMs stored EGMs. This was recognized in 6 (25%) of the 24 patients with retrograde 
conduction. In studies I and IV temporal loss of AV synchrony was not searched.
5.2 SENSING OF SINUS AND RETROGRADE ATRIAL BEATS
5.2.1 SENSING OF SINUS BEATS
In Study I with VDD pacing the programmed sensitivity level with a non fixed 
floating atrial sensing electrode which reliably detected atrial signal was 0.9 ± 0.8 
mV at 1-3 months follow-up, and 1.0 ± 0.8 mV at the last follow-up.  These were 
lower than the directly measured atrial signal amplitude during implantation, 2.1 
± 1.4 mV.  The programmed atrial sensitivity level at last follow-up visit was 0.26 
mV on average. Sustained and symptomatic atrial undersensing and thus loss of 
AV synchrony appeared in 11 patients (3.1%) needing reprogramming of the pacing 
mode to VVIR mode. Atrial undersensing occurred in 7.7% of patients with history 
of paroxysmal atrial fibrillation compared to 2.4% of patients without (P=0.042). 
No other pre-implant clinical characteristic was associated with atrial undersensing.
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In Study IV with DDD pacing measured atrial signals were stable in long term 
(mean P wave 2.69 ± 1.44 mV at 12 months). With the sensitivity setting of 0.3mV 
for all patients sustained and symptomatic atrial undersensing appeared only in 
one (0.3%) patients needing reprogramming of the sensitivity value.
5.2.2 SENSING RETROGRADELY CONDUCTED ATRIAL BEATS
In Study II data from atrial signals regarding to normal sinus and retrogradely 
activated atrias from 14 patients were collected in a test situation with a DDDR PM 
capable of DSP of intracardiac signals and analyzed off-line. Atrial signals differed 
markedly between upright and supine body postures. However, it was possible to 
discriminate retrograde from sinus atrial waves on the basis of at least one form 
parameter in 12 of 14 (86 %) patients when unipolar and bipolar atrial signals 
recorded in both body postures were analyzed separately. When body postures 
were pooled together to mimic natural conditions, discrimination was successful 
in 9 of 14 patients with either configuration of the atrial signal. 
In study III during the follow up period RNRVAS caused loss of AV synchrony 
and false MS in 6 (11%) out of 54 patients seen in PMs stored EGMs. With all these 
6 patients there were retrograde atrioventricular conduction seen after implantation 
with a long VA conduction time ranging from 150 ms to 500 ms. Also with these 
patients long AV-delays were used ranging from paced AV interval 275 ms to 350 
ms. The incidence of RNRVAS was as high as 25% among the patients in whom 
VA conduction was present. In Study IV clinical significant retrograde conduction 
was observed only with 2 (0.6%) patients.
5.3 FAR FIELD OVERSENSING OF VENTRICULAR SIGNALS
In Study III ventricular FF signals were measured profoundly. This data is to date 
unpublished. During sensed intrinsic atrial rhythm FF sensing test could only be 
done in 46 of these patients, due to extreme bradycardia. During intrinsic atrial 
rhythm FF sensing was seen only in one patient when the sensitivity was set to 0.5 
mV. With the most sensitive setting of 0.1 mV FF sensing was seen in 36 (69%) of 
the patients when the AV-interval was set to 50 ms and in 17 (37%) when 150 ms 
and in one patient when 300 ms respectively (Table 1a). FF sensing test during 
atrial pacing was performed in 54 patients. During atrial pacing FF sensing was 
seen also only in one and the same patient like within intrinsic rhythm when the 
sensitivity was set to 0.5 mV. With the most sensitivity setting of 0.1 mV FF sensing 
was seen only in 34 (64%) of the patients when the AV-interval was set to 50 ms 
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and in 28 (53%) when 150 ms respectively. When AV-interval was set to 300 ms 
no FF sensing was seen (Table 2b).
With the only patient where FFs were seen during the tests with 0.5 mV sensitivity 
the atrial lead was implanted in the appendage. During tests with highest sensitivity 
setting of 0.1 mV FF sensing was seen in 17 (72%) patients with the lead in appendage; 
with 11 (69%) leads in the septal position and with 5 (36%) lead in the free wall 
respectively. FF oversensing caused no false atrial tachyarrhythmia detection by the 
PM when commonly used atrial sensitivity setting of 0.5 mV and an individually 
adjusted PVAB was used during the study period of 3 months.
Table 1. Far field sensing test
a) During atrial sensing – number of patients with FF sensing
50 ms 150 ms 300 ms
0.1 mV 32 (46) = 69 % 17 1
0.3 mV 2 2 0
0.5 mV 1 0 0
1.0 mV 0 0 0
b) During atrial pacing – number of patients with FF sensing
50 ms 150 ms 300 ms
0.1 mV 34 (54) = 64% 28 = 53% 0
0.3 mV 4 = 8% 4 = 8% 0
0.5 mV 0 1 0
1.0 mv 0 0 0
In Study I with VDD pacing no far field sensing of the T wave or myopotentials 
in provocation test was observed. In Study IV with DDDR pacing with the used 
atrial sensitivity level of 0.3 mV and PVAB 125 ms or adapted +25 ms if FF was 
present, FF oversensing was seen only with 2 (0.6%) patients.
5.4 ADEqUATE SENSING OF ATRIAL TACHYARRHYTHMIAS 
A total of 60 patients with SND were enrolled in Study III. With DDDR pacing 
programmed with a fixed long AV delay at 3 months of follow-up, the mean percent 
atrial pacing was 85, for ventricular pacing 26, and mean MS duration was 5% of the 
total follow-up time. In 13 of 16 (81%) patients, whose Holter recording revealed the 
presence of ATs, episodes of AT sensing were retrieved from the PM memory with 
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EGM verifications, confirming that the devices had detected the ATs. Very short ATs 
seen in Holter recordings were missed by the PM with 3 patients. However, with all 
these patients after 3 months follow up period there were recognized periods of ATs 
by the PM. With 10 (17%) patients there were intermittent periods of undersensing 
by the PM although continuous AF was seen in the Holter recording. Retrograde 
conduction caused false AT detection due to RNRVAS in 6 (25%) of the 24 patients 
with retrograde conduction. 
5.5 IMPACT OF INTRINSIC AV CONDUCTION AND LEAD  
 LOCATIONS ON TIMING OF VENTRICULAR ACTIVATION 
A total of 415 patients were recruited in Study IV. At the 1 month visit 389 patients 
were classified after successful implantation of PM, 117 (30.1%) in the AVi group 
and 272 (69.9%) in the AVc group. 106 (39.0%) of the AVc group patients were 
allocated in this group because they failed to show 1:1 AV conduction on the AV 
conduction test. 
Indications for pacing were: SND in 309 (79%), intermittent AV block in 154 
(40%) and a bundle branch block in 79 (20%) of the patients. Intermittent AV 
block was first degree in 54 (14%), second degree in 56 (14%) and third degree in 
45 (12%) of the patients. The four lead locations in the right atria and two in the 
ventricle generated eight different atrioventricular pacing configurations.
First the change of intrinsic AV conduction was assessed from surface ECG PQ 
interval for both AVi and AVc groups at 1 and 12 months. The median PQ intervals 
at 1 month were in the AVi group 161ms ± 27 and in the AVc group 220ms ± 50 
and at 12 month in the AVi group 169ms ± 33 and in the AVc group 217ms ± 75. 
Even though the changes of intrinsic AV conduction intervals in both groups were 
scarce there was significant worsening seen only in the AVi group (p=0.028). 
In the AV conduction test atrial pacing with rates from 10 bpm above intrinsic 
sinus rate up to 120 bpm induced high grade AV block in 106 (39.0%) of the patients 
at 1 month and 113 (41.5%) at 12 months in the AVc group. At 12 months AV block 
was induced in 5 (4.3%) of the AVi group patients. Atrial paced ventricular sensed 
AV intervals with pacing rate 10 bpm above intrinsic rate could be measured when 
there was 1:1 AV conduction. At 1 month the mean interval was 169ms ± 34 in 
AVi patients and 261ms ± 69 in AVc patients then at 12 months 183ms ± 66 and 
260ms ± 51, respectively. Only with AVi group, worsening in atrial paced intrinsic 
AV conduction was observed even though the changes were scarce and statistically 
insignificant in both groups. 
Evaluation of intrinsic AV conduction with both ECG and AV conduction tests 
were made both at 1 and 12 months. In total, 261 (78%) patients had no change in 
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classification of intact (AVi) or compromised (AVc) AV conduction. 39 (12%) patients 
classified at 1 month in the AVi group were classified as having compromised (AVc) 
conduction at 12 month and conversely 33 (10%) of the patients classified at 1 month 
in the AVc group were classified as having intact AV conduction at 12 months.
The absolute difference between mean spontaneous PQ and paced AR intervals 
were longer with AVc (41ms) than AVi (8ms) patients at 1 month. The paced AV 
intervals at 1 month were also longer with AVc patients (mean 261ms) than with 
AVi (mean 169ms) patients.
When only comparing patients with VIP ON or OFF the mean %VP in groups with 
all different pacing configurations with VIP algorithm ON was < 40% in 80.1% of 
patients and < 10% in 62.4% of patients at 12 months. There was only one significant 
difference in the mean %VP among these four different pacing configurations. The 
mean %VP was significantly lower with patients that had leads in all other positions 
(9.2-18.7%) compared to patients that had leads in lateral-apical positions (46.8%) 
(P=0.0093). Conversely, when VIP algorithm was disabled the mean %VP in groups 
with all different pacing configurations was < 40% in 23.4% of patients and < 10% 
in 11.4% of patients at 12 months. The amount of mean %VP was < 40% only with 
patients that had leads in septal-septal position (23.0%). 
If a patient had leads in RA septal-RV septal positions it was more likely that 
they were classified in the AVi group (62.1% in the AVi group) than in the AVc 
group compared to the patients who had leads in appendage-apical (26.3% in the 
AVi group), appendage-septal (25.0% in the AVi group) or lateral- apical (16.2% 
in the AVi group) positions. 
5.6 THE PERFORMANCE OF AN ADVANCED AVSH ALGORITHM  
 AVOIDING UNNECESSARY VENTRICULAR PACING 
In Study IV at 1 month the mean ± SD of % ventricular pacing was 53.9 ± 37.2 
for all AVi patients and respectively 84.2 ± 24.7 for all AVc patients. The mean 
and median %VP at 12 months are shown in Table 2 for all patients in different 
groups. The tested AVSH algorithm reduced mean %VP in SND patients with both 
AVi (P<0.0001) and AVc (P<0.0001) group patients. At 12 months the absolute 
reduction in %VP with the tested AVSH algorithm is more pronounced in patients 
with compromised AV conduction. The absolute reduction in mean %VP was 56.3% 
with AVc patients and 44.3% with AVi patients respectively.
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Table 2. Percentage of ventricular pacing at 12 month for patients in both intact (AVi) and compromised 
(AVc) groups with regard to the use of AVSH algorithm.
Median%VP Mean%VP +SD
AVi
AVSH ON 1.0 9.6 ± 22.7
AVSH OFF 59.0 51.8 ± 37.9
AVc
AVSH ON 8.3 28.0 ± 35.6
AVSH OFF 97.0 78.9 ± 31.7
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6 DISCUSSION
6.1 MAINTAINING AV SYNCHRONY
Long term maintenance of AV synchrony with VDD mode pacing in high grade AV 
block patients is reasonably good, but inferior to dual lead DDDR mode pacing. 
Clinical history of atrial fibrillation and sinus node function and heart size in chest 
roentgenogram adequately permit selection of the VDD pacing mode in an elderly 
patient population. Significant sinus nodal dysfunction rarely develops during follow 
up. Patients with a history of paroxysmal atrial fibrillation and cardiac enlargement 
may benefit more from DDDR pacing, since they tend to lose atrial sensing function, 
progress to chronic atrial fibrillation and develop symptomatic sinus bradycardia. 
Also the fact that the VDD pacing lead is available only with passive ventricular 
fixation, limits the lead positioning to only the right ventricular apex. The knowledge 
of possible detrimental effects of RV apical pacing to left ventricular function limits 
the current use of VDD PMs. Even dual lead sensing has limitations in maintaining 
AV synchrony. Temporal loss of AV synchrony due to AF is very common and 
acceptable with all dual chamber pacing. Also RNRVAS can cause temporal loss of 
AV synchrony especially in patients with SND and retrograde conduction. Temporal 
loss of AV synchrony because of FF oversensing is very rare when FF signals are 
specifically sought and a commonly used atrial sensitivity setting of 0.5 mV is used 
and individually adjusted PVAB is programmed 125 ms or adapted + 25 ms in the 
presence of FF signals. 
6.2 DETECTION OF ATRIAL ACTIVATION DIRECTION
With current analogue PM technology, atrial signals are classified merely on the 
basis of the time-lag between consecutive sensed events. With digital PMs it is 
feasible to continuously monitor and classify every sensed event by using specific 
form parameters, thereby dramatically increasing the amount of information that 
can be processed and stored. Algorithms using morphology and timing criteria 
might significantly improve atrial signal sensing and classification, since they allow 
for high atrial sensitivity and short blanking periods. Retrograde atrial waves can 
be discriminated from sinus waves by using a high sampling rate and algorithms 
for digital signal processing. This supports the development of specific methods of 
analyzing sinus and retrograde atrial signals in real time in dual-chamber pacing 
devices. This approach could enhance the capability of future pacing devices to adapt 
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their stimulation to the spontaneous heart rhythm and improve the collection of 
diagnostic information on arrhythmias. 
6.3 PROPER SENSING OF ATRIAL ARRHYTHMIAS
The atrial tachyarrhythmia sensing algorithms incorporated in a state-of-the art 
DDDR pacemaker can accurately identify patients who develop ATs. However 
transient undersensing of continuous AF and failure to detect very short episodes 
of ATs can occur frequently, despite the use of refined detection algorithms. Whether 
a more sensitive setting than 0.5 - 0.3 mV can eliminate the undersensing of AF is 
the scope of an ongoing study to determine the sensitivity of a dual chamber PM to 
identify ATs in patients implanted with a short tip-to-ring spacing bipole lead with 
atrial sensitivity setting of  0.2 mV and an short 60 ms blanking (PVAB) period. 
When commonly used atrial sensitivity settings of 0.5-0.3 mV and an individually 
adjusted PVAB is used, FF oversensing rarely causes false atrial tachyarrhythmia 
detection by the PM. It is of notice that FF signals are dependent on the lead location 
in the right atrium. FF signals were twice as commonly seen with high sensitivity 
values in our study when the lead was in the appendage or in the septal position 
than with the lead in the free wall. Thus in regard for avoiding inapropriate MS due 
to FF oversensing the free wall of the right atrium seems to be the best position 
for the atrial lead. However, other factors must be taken into consideration when 
implanting an atrial lead, including a possible worsening of interatrial conduction. 
We also observed in the FF sensing test that with shorter programmed AV delays the 
FF ventricular signals were more often sensed in the atrial channel. This was probably 
due to increased amount of ventricular pacing related to shorter programmed AV 
delays. Ventricular pacing, especially RV apical pacing like in our study, induces 
delayed depolarization of the left ventricular free wall which can cause more often 
FF oversensing beyond the PVAB setting of 60 ms used in the FF sensing test in our 
study. This observation emphasizes the need of  individual recognition of  possible FF 
signals especially when more sensitive than 0.5 mV atrial sensitivity values are used.
When a long AV delay is programmed to avoid unnecessary RV pacing, 
inappropriate MS due to RNRVAS is relatively common with SND patients in 
the presence of VA conduction. These finding accords with the results found in 
a recent PM study, where long AV delays were also used and EGM verifications 
of AT episodes were collected (Kaufman et al. 2012). RNRVAS can thus cause 
erroneous diagnostics of AF with inappropriate clinical decisions. In every day 
clinical practice with dual chamber pacing RNRVAS is less frequently recognized 
than in our study probably because commonly higher atrial tachycardia detection 
rates (ATDR) are used and EGM verifications of MSs and AT episodes are not usually 
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collected. The scrutiny of EGMs to verify the accurate detection of MS and ATs by 
currently available DDDR pacemakers is important to avoid their misclassification 
and erroneous interpretation. Furthermore, the detection of VA conduction has 
become particularly important when long AV delays are programmed, or when an 
AVSH algorithm to limit the percentage of ventricular pacing is used. In DDDR 
pacing in the presence of VA conduction, a long PVARP should be programmed to 
prevent PMT. The programming of a long AV delay and a long PVARP facilitates 
RNRVAS in both DDDR and DDIR pacing. This applies to both long fixed AV 
delay programming and the use of different algorithms with periodic automated 
extension of the programmed AV interval (AVSH algorithms) (Barold et al. 2001, 
Dennis et al. 2004, Velasquez-Castano et al. 2010). 
6.4 CONSEqUENCES OF ATRIAL PACING TO INTRA-AND   
 INTER-ATRIAL CONDUCTION 
Atrial pacing can cause undesirable atrial desynchronization and further prolong 
conduction times (Roithinger et al. 2001, Strohmer et al. 2004, Belham et al. 
2002). We saw in Study IV, as a new finding, that atrial pacing desynchronizes and 
prolongs intra-and inter-atrial conduction more if the AV conduction was initially 
compromised compared to if the AV conduction initially was normal. Furthermore, 
we saw that the atrial paced and ventricular sensed AV delays in patients with 
impaired AV conduction were notably long and higher atrial pacing rates further 
impaired AV conduction. Consequently almost half of the patients lost 1:1 AV 
conduction with higher atrial pacing rates, thus highly effective prevention of VP 
after atrial pacing appear unlikely also when an advanced AVSH algorithm is used 
with these patients. On the contrary, in patients with intact AV conduction, the atrial 
paced ventricular sensed AV interval rarely exceeded the maximal programmed AVI 
value of 350ms and only a minority of the patients lost 1:1 conduction with higher 
pacing rates. Thus the mean %VP with the use of an advanced AVSH algorithm 
keeps reasonably low.
The different atrial and also ventricular lead locations have an influence on 
PMs AV timing and on the amount of ventricular pacing. In the Study IV with RA 
septal-RV septal lead positions it was more likely that the patient had shorter AV 
conduction times compared to if the leads were in RA appendage-RV apical or RA 
lateral-RV apical positions. However with the used AVSH algorithm only patients 
with RA lateral-RV apical lead positions (<10% of all patients in the study) excessive 
amount of VP (median >40%) was seen. Conversely when the AVSH algorithm was 
not used and commonly used AV delays were programmed it was only in patients 
with RA septal-RV septal lead positions where unnecessary VP could be avoided.
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6.5 TRADE OFF BETWEEN PHYSIOLOGICAL AV DELAYS AND  
 UNNECESSARY VENTRICULAR PACING IN PATIENTS WITH  
 INTACT AND COMPROMISED AV CONDUCTION IN DUAL  
 CHAMBER PACING
In dual chamber pacing avoiding unnecessary ventricular pacing and on the 
other hand pacing the ventricles when it is considered inevitable for achieving 
physiological timing, is preferable (Ellenbogen et al. 2011). A common perception 
is that AF, HF hospitalizations and death in patients with SND show long term 
reductions if %VP is kept below 40% and minimized when %VP falls close to 
10% (Sweeney et al. 2003, Wilkoff et al. 2002, Olshansky et al. 2007). This can 
be achieved by using a fixed long AV interval or with algorithms, which employ 
automatic switching between AAIR and DDDR modes or by AVSH algorithms. A 
common perception is also that excessive (>350ms) atrial paced AVIs, which fixed 
long AVIs and AAIR-DDDR algorithms allow, can be hemodynamically detrimental 
and are linked to symptomatic episodes especially during exercise and increased risk 
of AF and all cause mortality (Sweeney et al. 2010, Stocburger et al. 2009). Although 
hemodynamics during normal ventricular activation are generally acknowledged to 
be superior to right ventricular pacing, hemodynamics during ventricular pacing 
with physiological AVIs seem to be superior to normal ventricular activation when 
the atrial paced AVI exceeds 270 ms (Iliev et al. 2000). Thus the promotion of 
more physiological AVIs may outweigh the slight increment of potentially harmful 
VP with the use of AVSH algorithms compared to the frailties of AAIR-DDDR 
algorithms to minimize VP. Since extremely long AV delays or high grade AV block 
may adversely influence left ventricular filling and impair cardiac output (Ishikawa et 
al.1992, Sweeney et al. 2010) the restoration of more physiological AV delays (atrial 
paced ventricular paced AV delay of 250ms) with an advanced AVSH algorithm and 
consequently achieved moderate proportion of VP, as in our study, with patients 
having compromised AV conduction seems reasonable.
The presented Study IV also shows that although in the majority of patients the 
AV conduction is quite stable, there remains a non negligible minority of patients 
where the AV conduction could both worsen (in 12%) or conversely recover (in 10%) 
over time. It seems that an advanced AVSH algorithm, with indefinite search for 
intrinsic AV conduction is useful and the obligation of the PM physician to check 
PMs event counters and ECGs during frequent follow-ups in patients with impaired 
AV conduction becomes less important. 
Thus in the long term an AVSH algorithm, that promotes intrinsic AV conduction 
with the reduction of unnecessary VP but not at the cost of unphysiologically long 
AVIs, could decrease the incidence of AF. 
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7 CONCLUSIONS
1. Adequate sinus-driven atrial rate and no history of paroxysmal atrial 
fibrillation or cardiac enlargement predict maintenance of the VDD pacing 
mode in elderly patients treated for heart block. However, maintenance of 
AV synchrony with VDD mode pacing compared to DDDR mode is inferior 
but still reasonably good. 
2. Retrograde atrial waves can be discriminated from sinus waves in many patients 
by using a high sampling rate and algorithms for digital signal processing with 
data collected by a PM. This supports the development of specific methods 
of analyzing sinus and retrograde atrial signals in real time in dual-chamber 
devices. This approach could enhance the capability of future devices to adapt 
their stimulation to the spontaneous heart rhythm and improve the collection 
of diagnostic information on arrhythmias. The performed studies indicated 
that the recognition of retrograde atrial waves is important in clinical dual 
chamber pacing. 
3. The AT sensing algorithms incorporated in a state-of-the art DDDR pacemaker 
can be programmed to accurately identify patients who develop ATs. However 
transient undersensing of continuous AF and failure to detect very short episodes 
ATs can occur frequently, despite the use of refined detection algorithms. 
RNRVAS in sinus node disease patients with retrograde VA conduction is a 
common reason for erroneous AT detection. On the other hand erroneous AT 
detection due to the sensing of FF signals can be effectively prevented by the 
individual adjustment of PVAB.
4. In SND patients with DDDR pacing programmed with a fixed long 
atrioventricular delay the mean %VP seems to be reasonably low. Also in SND 
patients with both normal and impaired AV conduction and in patients with 
intermittent heart block an advanced AVSH algorithm significantly reduces 
the incidence of unnecessary ventricular pacing. The reduction in %VP with 
this algorithm is even more pronounced in patients with compromised AV 
conduction.
      The overall sustainability of the DDDR pacing mode is excellent. However, 
with a fixed, long AV delay in DDDR pacing, temporal disruption of AV synchrony 
and inappropriate MS due to RNRVAS is relatively common with SND patients 
in the presence of VA conduction. On the contrary, episodes of retrograde 
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conduction rarely have clinical consequences when shorter AV delays and an 
AVSH algorithm are used.
       Although AT episodes are very common with PM patients DDDR pacing mode 
seems to be permanently lost due to development of chronic atrial fibrillation 
in the long term, only in a small minority of patients. 
5. An advanced AVSH algorithm reduces incidence of unnecessary ventricular 
pacing in the majority of SND patients with both intact and impaired AV 
conduction and in patients with intermittent AV block, regardless of the lead 
positions in the right atrium and the ventricle.
       Compared to only AAIR pacing or DDDR pacing with AAIR-DDDR algorithms 
the avoidance of RV pacing with an AVSH algorithm is not associated with over-
long AV delays.
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